Needham & Company
Needham & Company Reiterates a 'Buy' on MELA Sciences (MELA); First Commercial Revenue From MelaFind
-
Needham & Company Reiterates a 'Buy' on MELA Sciences (MELA); Updating Our Earnings Model
-
Morning Movers 09/16: (MELA) (DMND) (XOMA) Higher; (RIMM) (NEP) (PCX) Lower
-
Needham & Company Maintains a 'Buy' on MELA Sciences (MELA); Receives CE Mark to Sell in Europe
-
Needham & Company Reiterates a 'Buy' on MELA Sciences (MELA); MelaFind Receives Positive Panel Vote
-
Needham & Company Maintains a 'Buy' on Mela Sciences (MELA); Updating Model
-
MELA Sciences (MELA) Prices 2.2M Common Offering at $7.50/Share
-
Needham & Company Maintains a 'Buy' on Electro-Optical Sciences (MELA); Accumulate Shares on Pullback

